DiscoverEndocrine Feedback LoopEFL053 - The Cost Effectiveness of Molecular Testing for Indeterminate Thyroid Nodules
EFL053 - The Cost Effectiveness of Molecular Testing for Indeterminate Thyroid Nodules

EFL053 - The Cost Effectiveness of Molecular Testing for Indeterminate Thyroid Nodules

Update: 2024-09-19
Share

Description

Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism about the impact of molecular testing for indeterminate thyroid nodules. He talks with Anupam Kotwal, MD, from the University of Nebraska Medical Center, and guest expert Sarah Mayson, MD, from the University of Colorado School of Medicine. The article featured this month, by Lévesque et al, was first published online in May 2024: “Publicly Funded Molecular Testing of Indeterminate Thyroid Nodules: Canada’s Experience.” Show notes can be found at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl053-the-cost-effectiveness-of-molecular-testing-for-indeterminate-thyroid-nodules — podcast home page: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

EFL053 - The Cost Effectiveness of Molecular Testing for Indeterminate Thyroid Nodules

EFL053 - The Cost Effectiveness of Molecular Testing for Indeterminate Thyroid Nodules